- 1. vacation home
- [A vacation home, to reach a person while on vacation. ( HL7V3.0 )] (UMLS (HL7) C1550702) =Spatial Concept =home address;
| - 14. Vaccine Therapy
- [Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system. ( NCI )] (UMLS (NCI) C0042209) =Therapeutic or Preventive Procedure
|
- 2. Vacation Home Number
- (UMLS (HL7) C1549670) =Intellectual Product =Telecommunication use code;
| - 15. Vaccine-Draining Lymph Node Lymphocyte Therapy
- (UMLS (NCI) C0879364) =Therapeutic or Preventive Procedure ;
|
- 3. Vacation Supply
- [Supply date is due to patient vacation ( HL7V3.0 )] (UMLS (HL7) C1555303) =Intellectual Product =Supply Appropriate;
| - 16. Vaccine-Sensitized Draining Lymph Node Cells
- [Cells isolated from lymph nodes from patients, and activated in vitro to generate tumor-specific effector T cells. Lymph nodes in the lymphatics draining tumors often contain T cells that are immunologically sensitized but functionally deficient. Vaccine-sensitized draining lymph node cells are prepared by isolating these lymphocytes in vitro and stimulating them with cytokines to differentiate into mature effector cells. Vaccine-draining lymph node cells may also be produced by pharmacological activation of lymph node-derived lymphocytes with drugs such as ionomycin or with bacterial toxin; these activated lymphocytes may be expanded in culture with cytokines such as interleukin-2 prior to infusion into the patient. (NCI04) ( NCI )] (UMLS (NCI) C0879357) VDLN Cells =Cell ;
|
- 4. vaccination
- [Treatment with a vaccine. ( NCI )] (UMLS (NCI) C0042196) =Therapeutic or Preventive Procedure ;
| - 17. VaccineManufacturer
- [The manufacturer of a vaccine. ( HL7V3.0 )] (UMLS (HL7) C1553793) =Intellectual Product =CodeSystem;
=Alpha Therapeutic Corporation;
Aviron;
Chiron Corporation;
Greer Laboratories, Inc.;
Immuno International AG;
Immuno-U.S., Inc.;
Korea Green Cross Corporation;
Massachusetts Public Health Biologic Laboratories;
MedImmune, Inc.;
Merck & Co., Inc.;
North American Vaccine, Inc.;
New York Blood Center;
Organon Teknika Corporation;
Sclavo, Inc.;
Abbott Laboratories (includes Ross Products Division);
Adams Laboratories;
Armour [Inactive - use CEN];
More… |
- 5. Vaccination against yellow fever
- [ ] (UMLS (ICD9CM) C0199823) =Therapeutic or Preventive Procedure
| - 18. Vaccines administered (code = CVX)(parenteral, unless oral is noted)
- (UMLS (HL7) C1547693) =Pharmacologic Substance; Immunologic Factor =HL7 Vocabulary Version 2.5;
=Bacille Calmette-Guerin Live;
botulinum antitoxin;
cholera;
diphtheria antitoxin;
DTP;
[IM500] IMMUNOGLOBULINS;
flu vaccine;
measles;
mumps;
pertussis;
plague;
OPV;
RABIES VACCINE;
rubella;
smallpox;
TETANUS TOXOID;
TYPHOID VACCINE;
leprosy;
CMVIG;
HBIG;
Hep B, NOS;
MMR;
MMRV;
Chickenpox Vaccine;
VARICELLA ZOSTER IMMUNE GLOBULIN;
GLOBULIN,IMMUNE (IV);
HIV;
meningococcal;
Hep A, More… |
- 6. Vaccination not carried out
- [ ] (UMLS (ICD9CM) C1561700) =Finding
| - 19. VaccineType
- [The kind of vaccine. ( HL7V3.0 )] (UMLS (HL7) C1554000) =Intellectual Product =CodeSystem;
=Bacille Calmette-Guerin Live;
botulinum antitoxin;
cholera;
diphtheria antitoxin;
DTP;
[IM500] IMMUNOGLOBULINS;
flu vaccine;
measles;
mumps;
pertussis;
plague;
OPV;
RABIES VACCINE;
rubella;
smallpox;
TETANUS TOXOID;
TYPHOID VACCINE;
leprosy;
CMVIG;
HBIG;
Hep B, NOS;
MMR;
MMRV;
Chickenpox Vaccine;
VARICELLA ZOSTER IMMUNE GLOBULIN;
GLOBULIN,IMMUNE (IV);
HIV;
meningococcal;
Hep More… |
- 7. Vaccination record response
- (UMLS (HL7) C1548130) =Idea or Concept =Message type;
| - 20. vaccinia immune globulin
- [vaccinia immune globulin ( HL7V3.0 )] (UMLS (HL7) C1548487) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 8. Vaccine
- [A Type of medicine that creates an immune protection without the recipient experiencing the disease. ( HL7V3.0 )] (UMLS (HL7) C1552558) =Intellectual Product ;
=MaterialEntityClassType;
| - 21. Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine
- (UMLS (NCI) C1328073) =Therapeutic or Preventive Procedure ;
|
- 9. vaccine delivery
- [ ] (UMLS (CSP) C1331096) =Health Care Activity
| - 22. Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- [A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA. ( NCI )] (UMLS (NCI) C1327973) Vaccinia-PSA-TRICOM Vaccine =Pharmacologic Substance; Immunologic Factor
|
- 10. vaccine development
- [development of prophylactic preparation which is given to produce immunity to pathogenic organisms or neoplasms. ( CSP )] (UMLS (CSP) C0597634) =Research Activity ;
=immunologic substance development/preparation;
| - 23. VaccinOvar
- (UMLS (NCI) C1328701) =Pharmacologic Substance; Immunologic Factor ;
|
- 11. vaccine evaluation
- [any process by which immunogenicity, immune response, toxicity, metabolism, absorption, preferred route of administration, safe dosage range, etc., for a vaccine or group of vaccines is determined through assessment in humans, animals or cells. ( CSP )] (UMLS (CSP) C1171370) vaccine screening;
vaccine testing =Research Activity ;
=evaluation/testing;
| - 24. Vacuolar
- [Any membrane-enclosed spaces or cavities within a cell. ( NCI )] (UMLS (NCI) C0042219) =Cell Component
|
- 12. vaccine evaluation center
- [ ] (UMLS (CSP) C1328964) =Manufactured Object; Health Care Related Organization
| - 25. VACUUM EXT DEL W EPISIOT
- [ ] (UMLS (ICD9CM) C0177270) =Therapeutic or Preventive Procedure
|
- 13. Vaccine Information
- (UMLS (HL7) C1546482) =Idea or Concept =What subject filter;
| - 26. Vacuum extraction
- [Removal of the fetus from the uterus or vagina at or near the end of pregnancy with a metal traction cup that is attached to the fetus' head. Negative pressure is applied and traction is made on a chain passed through the suction tube. (From Stedman, 26th ed & Dorland, 28th ed) ( MSH )] (UMLS (ICD9CM) C0042225) =Therapeutic or Preventive Procedure
|
home
